Table 1

Baseline clinical and echocardiographic characteristics

Acute MI n=68Previous MI n=45Control n=101P value
Clinical characteristics
 Age (years)73.4±9.375.0±8.274.1±8.90.64
 Female sex, n (%)27 (40%)*6 (13%)*†47 (46%)†0.0008
 Body surface area (m2)1.84±0.231.90±0.211.85±0.210.35
 Smoking history, n (%)48 (71%)‡29 (64%)†46 (46%)‡†0.003
 Diabetes mellitus, n (%)36 (53%)‡16 (36%)26 (26%)‡0.002
 Dyslipidaemia, n (%)52 (76%)40 (89%)†68 (67%)†0.02
 Hypertension, n (%)57 (84%)37 (82%)79 (78%)0.64
 CKD, n (%)21 (31%)‡15 (33%)†17 (17%)‡†0.038
 CAD, n (%)68 (100%)‡45 (100%)†34 (34%)‡†<0.0001
 BAV, n (%)4 (6%)1 (2%)7 (7%)0.68
 Beta-blocker, n (%)53 (78%)‡34 (76%)†36 (36%)‡†<0.0001
 ARB, n (%)8 (12%)‡*15 (33%)*36 (36%)‡0.002
 ACEI, n (%)42 (62%)‡20 (44%)†24 (24%)‡†<0.0001
 Statin, n (%)65 (96%)‡42 (93%)†66 (65%)‡†<0.0001
Echocardiographic characteristics
 AVAi (cm2/m2)0.69±0.180.64±0.170.65±0.160.26
 AVA (cm2)1.28±0.361.20±0.321.20±0.290.17
 VTI ratio0.331±0.0880.307±0.0810.332±0.0830.25
 MG (mm Hg)15.3±8.317.4±6.717.8±9.20.16
 Vpeak (m/s)2.54±0.59‡2.75±0.492.78±0.58‡0.028
 LVEF (%)50.0±10.6‡*55.7±12.5*†66.2±6.6‡†<0.0001
 SVi (mL/m2)35.4±9.4‡39.2±9.138.9±7.6‡0.017
 LVET (ms)287±36‡*315±38*306±35‡0.0001
 Flow rate (mL/s)226±55236±59235±440.50
 ≥Moderate AR, n (%)1 (1%)2 (4%)3 (3%)0.41
  • *P<0.05 for comparison acute versus previous MI groups.

  • †P<0.05 for comparison previous MI versus control groups.

  • ‡P<0.05 for comparison acute MI versus control groups.

  • ACEI, ACE inhibitor; AR, aortic valve regurgitation; ARB, angiotensin-2 receptor blocker; AVA, aortic valve area; AVAi, indexed aortic valve area; BAV, bicuspid aortic valve; CAD, coronary artery disease; CKD, chronic kidney disease; LVEF, left ventricular ejection fraction; LVET, left ventricular ejection time; MG, mean aortic gradient; MI, myocardial infarction; SVi, indexed stroke volume; Vpeak, aortic peak jet velocity; VTI, velocity-time integral.